Skip to main content

Table 1 Patient characteristics and clinicopathological variables, and their prognostic value for the three endpoints in 535 prostate cancer patients (univariate analyses; log rank test)

From: Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time

Characteristic

Patients

Patients

BF

CF

PCD

(n)

(%)

(170 events)

(36 events)

(15 events)

  

5-year EFS (%)

p

10-year EFS (%)

p

10-year EFS (%)

p

Age

   

0.55

 

0.085

 

0.600

  ≤ 65 years

357

67

76

 

92

 

97

 

  > 65 years

178

33

70

 

88

 

96

 

pT-stage

   

<0.001

 

<0.001

 

0.027

  pT2

374

70

83

 

96

 

98

 

  pT3a

114

21

60

 

86

 

98

 

  pT3b

47

9

43

 

73

 

89

 

pN-stage

   

<0.001

 

<0.001

 

<0.001

  NX

264

49

79

 

95

 

98

 

  N0

268

50

71

 

89

 

97

 

  N1

3

1

0

 

33

 

67

 

Preop PSA

   

<0.001

 

0.085

 

0.061

  PSA < 10

308

57

80

 

93

 

99

 

  PSA > 10

221

42

67

 

88

 

95

 

  Missing

6

1

-

 

-

 

-

 

Gleason

   

<0.001

 

<0.001

 

0.001

  3 + 3

183

34

83

 

98

 

99

 

  3 + 4

220

41

76

 

93

 

98

 

  4 + 3

80

15

69

 

84

 

95

 

  4 + 4

19

4

63

 

76

 

94

 

  ≥9

33

6

34

 

67

 

87

 

Tumor size

   

<0.001

 

0.019

 

0.098

  0-20 mm

250

47

82

 

94

 

99

 

  >20 mm

285

53

67

 

88

 

96

 

PNI

   

<0.001

 

<0.001

 

0.002

  No

401

75

79

 

95

 

98

 

  Yes

134

25

60

 

81

 

93

 

PSM

   

0.041

 

0.038

 

0.697

  No

249

47

81

 

94

 

97

 

  Yes

286

53

69

 

89

 

97

 

Non-apical PSM

   

<0.001

 

<0.001

 

0.029

  No

381

71

81

 

95

 

98

 

  Yes

154

29

57

 

81

 

94

 

Apical PSM

   

0.04

 

0.484

 

0.31

  No

325

61

73

 

90

 

96

 

  Yes

210

39

77

 

92

 

98

 

LVI

   

<0.001

 

<0.001

 

0.009

  No

492

92

77

 

93

 

98

 

  Yes

43

8

46

 

71

 

88

 

Surgical proc

   

0.23

 

0.41

 

0.581

  Retropubic

435

81

76

 

90

 

97

 

  Perineal

100

19

67

 

95

 

98

 
  1. Abbreviations: BF biochemical failure, CF Clinical failure, EFS event free survival in months, LVI lymphovascular infiltration, PCD prostate cancer death, NR not reached, P P value for log rank statistic for difference in event free survival, PC Prostate cancer, PNI Perineural infiltration, Post op RT postoperative radiotherapy, Preop preoperative, PSA Prostate specific antigen, PSM Positive surgical margin, Surgical proc surgical procedure. Significant p-values in bold (threshold p ≤ 0.05).